Tomasz Zieliński Selected Research

Heart Failure

1/2023	L-arginine and Its Derivatives Correlate with Exercise Capacity in Patients with Advanced Heart Failure.
1/2023	Heart failure medical therapy before and after left ventricular assist device implantation.
12/2021	Titin-Related Dilated Cardiomyopathy: The Clinical Trajectory and the Role of Circulating Biomarkers in the Clinical Assessment.
1/2021	Transcatheter pulmonary denervation in patients with left heart failure with reduced ejection fraction and combined precapillary and postcapillary pulmonary hypertension: A prospective single center experience.
12/2020	The elevated serum parathyroid hormone level is associated with the occurrence of atrial fibrillation in patients with advanced heart failure.
10/2017	A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fraction.
1/2016	Prognostic significance of reactive pulmonary hypertension in patients with chronic heart failure listed for elective heart transplantation.
9/2015	Pulsatile-flow mechanical circulatory support (MCS) as a bridge to transplantation or recovery. Single-centre experience with the POLCAS system in 2014.
1/2015	Prognostic value of novel biomarkers compared with detailed biochemical evaluation in patients with heart failure.
1/2012	Severe chronic heart failure in patients considered for heart transplantation in Poland.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomasz Zieliński Research Topics

Disease

13	Heart Failure 01/2023 - 01/2010
7	Neoplasms (Cancer) 10/2023 - 03/2013
6	Carcinoma (Carcinomatosis) 05/2023 - 03/2013
4	Pulmonary Hypertension 01/2021 - 01/2014
3	Urinary Bladder Neoplasms (Bladder Cancer) 10/2023 - 09/2020
3	Hemorrhage 01/2017 - 10/2003
3	Wounds and Injuries (Trauma) 01/2016 - 05/2010
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2024 - 06/2014
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2021 - 01/2017
2	Weight Loss (Weight Reduction) 10/2018 - 11/2012
2	Hypertension (High Blood Pressure) 11/2017 - 05/2005
1	Drug Resistant Epilepsy 01/2023
1	COVID-19 11/2022
1	Neuroblastoma 01/2022
1	Cardiogenic Shock 12/2021
1	Left Ventricular Dysfunction 12/2021
1	Atrial Fibrillation 12/2020
1	Atrophy 03/2020
1	Incisional Hernia 10/2018
1	Basal Cell Carcinoma (Rodent Ulcer) 05/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2018
1	familial dilated cardiomyopathy 01/2018
1	Cardiac Arrhythmias (Arrythmia) 01/2018
1	Ventricular Tachycardia 01/2018
1	Coronary Disease (Coronary Heart Disease) 11/2017
1	Heart Arrest (Cardiac Arrest) 11/2017
1	Obesity 11/2017
1	Weight Gain 11/2017
1	Cholecystitis 01/2016
1	Gallstones (Gallstone) 01/2016
1	Ischemic Stroke 09/2015
1	Cardiac Tamponade 09/2015
1	Renal Insufficiency (Renal Failure) 09/2015
1	Wound Infection (Wound Infections) 09/2015
1	Edema (Dropsy) 06/2015
1	Cardiomyopathies (Cardiomyopathy) 04/2015
1	Stroke (Strokes) 03/2015
1	Neurocognitive Disorders (Clerambault Syndrome) 03/2015
1	Congenital Abnormalities (Deformity) 03/2015
1	Pain (Aches) 02/2015
1	Breast Neoplasms (Breast Cancer) 02/2015
1	Lipodystrophy 12/2014
1	Cicatrix (Scar) 12/2014
1	Essential Hypertension 06/2014

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 12/2021 - 07/2010
2	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2022
2	LectinsIBA 10/2023 - 05/2023
2	LipidsIBA 05/2023 - 11/2017
2	Protein Isoforms (Isoforms)IBA 01/2017 - 09/2003
2	PlasticsIBA 01/2016 - 05/2010
2	Hormones (Hormone)IBA 02/2015 - 10/2003
1	CholesterolIBA 01/2024
1	plants leukoagglutininsIBA 10/2023
1	SiliconesIBA 10/2023
1	OligosaccharidesIBA 05/2023
1	Polysaccharides (Glycans)IBA 05/2023
1	Proteins (Proteins, Gene)FDA Link 05/2023
1	Arginine (L-Arginine)FDA Link 01/2023
1	CenobamateIBA 01/2023
1	Viral RNAIBA 11/2022
1	WastewaterIBA 11/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	pro-brain natriuretic peptide (1-76)IBA 12/2021
1	ConnectinIBA 12/2021
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2021
1	Parathyroid Hormone (Parathormone)IBA 12/2020
1	polyacrylamide gelsIBA 09/2020
1	Quinidine (Chinidin)FDA LinkGeneric 01/2018
1	Blood Group Antigens (Blood Groups)IBA 11/2017
1	CatecholaminesIBA 11/2017
1	nitroxylIBA 10/2017
1	Nonsense Codon (Nonsense Mutation)IBA 01/2017
1	Erythropoietin FDA Link 01/2017
1	Coloring Agents (Dyes)IBA 06/2015
1	Amino Acids FDA Link 04/2015
1	phospholambanIBA 04/2015
1	Sarcoplasmic Reticulum Calcium-Transporting ATPasesIBA 04/2015
1	AlbuminsIBA 06/2014

Therapy/Procedure

7	Therapeutics 01/2023 - 10/2003
6	Heart Transplantation (Grafting, Heart) 01/2016 - 01/2010
3	Surgical Flaps 12/2022 - 12/2016
3	Transplantation 11/2017 - 03/2013
2	Denervation 01/2021 - 01/2020
2	Operative Surgical Procedures 02/2015 - 12/2014
1	Heart-Assist Devices 01/2023
1	Mastoidectomy 12/2022
1	Extracorporeal Membrane Oxygenation 12/2021
1	Rejuvenation 03/2020
1	Abdominoplasty 10/2018
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 10/2018
1	Length of Stay 10/2018
1	Laparoscopic Cholecystectomy 01/2016
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 03/2015
1	Drug Therapy (Chemotherapy) 02/2015
1	Surgical Amputation (Amputations) 02/2015
1	Radiotherapy 02/2015
1	Mammaplasty (Breast Reconstruction) 02/2015
1	Mastectomy (Mammectomy) 02/2015
1	Tissue Expansion Devices (Tissue Expander) 12/2014
1	Body Contouring 11/2012